Pharma Deals Review, Vol 2003, No 32 (2003)

Font Size:  Small  Medium  Large

Purdue Pharma Acquires Shire’s OTC Portfolio for US$72 M

Business Review Editor

Abstract


Purdue Pharma acquired the portfolio of over-the counter (OTC) products of Shire’s Pharmaceuticals for US$72 M. The acquisition includes branded laxatives and dietary supplements including Colace®, Peri-Colace® and Slow-Mag®.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.